Drug Combinations with Proteasome Inhibitors in Antitumor Therapy

E-ISSN： 1873-4286|19|22|4094-4114

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.22, 2013-07, pp. : 4094-4114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome Inhibitors in Cancer Therapy

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 968-981

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors

Current Cancer Drug Targets, Vol. 5, Iss. 7, 2005-11 ,pp. : 529-541

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of proteasome inhibitors in cancer therapy

By Sterz Jan Metzler Ivana von Hahne Jens-Claus Lamottke Britta Rademacher Jessica Heider Ulrike Terpos Evangelos Sezer Orhan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 879-895

Informa Healthcare

Access to resources Recommend Favorite

Progress of Computer-Aided Drug Design (CADD) of Proteasome Inhibitors

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2931-2944

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (The Ubiquitin Proteasome System as a Source of Drug Targets for Cancer Therapy)

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4024-4024

Bentham Science Publishers

Access to resources Recommend Favorite